RespireRx Pharmaceuticals Inc. Announces Publication of Phase 2B PACE Study: Once per Night Treatment with Dronabinol Provides Statistically Significant Improvement in Clinical Measures of Obstructive Sleep Apnea
30 nov. 2017 08h45 HE
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J, Nov. 30, 2017 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”) announces that the results of the PACE (Pharmacotherapy of Apnea by...
SANUWAVE to Hold Second Quarter 2012 Financial Results Conference Call on Thursday, August 9
06 août 2012 16h30 HE
|
SANUWAVE Health, Inc.
ALPHARETTA, Ga., Aug. 6, 2012 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV), an emerging regenerative medicine company focused on the development and commercialization of noninvasive,...
Florida PACE Association Launches Website, Toll-Free Number
16 août 2011 12h06 HE
|
Florida PACE Association
FORT MYERS, FL--(Marketwire - Aug 16, 2011) - The Florida PACE Association has launched an informational website and toll-free number for those interested in learning more about the Program for...
Del-Sano Completes LIFE at Saint Michael's PACE Center in Newark, New Jersey
06 juin 2011 09h48 HE
|
Del-Sano
UNION, NJ--(Marketwire - Jun 6, 2011) - Del-Sano Contracting Corporation, a general contracting, design/build and construction management services firm, today announced the completion of construction...